Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Ingelman-Sundberg

Showing results (21-30 of 284) with videos related to

Pageof 29
Sort By:
Cellular Signalling|September 29, 2004
Regulation of aryl hydrocarbon receptor signal transduction by protein tyrosine kinasesMaria Backlund, Magnus Ingelman-Sundberg
Drug News & Perspectives|January 31, 2009
Current research in drug metabolism, drug transport and drug developmentInger Johansson, Magnus Ingelman-Sundberg
Expert Review of Clinical Pharmacology|January 16, 2014
Pharmacoepigenetic aspects of gene polymorphism on drug therapies: effects of DNA methylation on drug responseAlvin Gomez, Magnus Ingelman-Sundberg
Methods in Molecular Biology (Clifton, N.J.)|March 12, 2013
Update on allele nomenclature for human cytochromes P450 and the Human Cytochrome P450 Allele (CYP-allele) Nomenclature DatabaseSarah C Sim, Magnus Ingelman-Sundberg
NPJ Genomic Medicine|March 21, 2020
Emerging strategies to bridge the gap between pharmacogenomic research and its clinical implementationVolker M Lauschke, Magnus Ingelman-Sundberg
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 1, 2018
Current Statistical Metrics Are Pragmatic Measures to Compare the Predictive Quality of Preclinical AssaysMagnus Ingelman-Sundberg, Volker M Lauschke
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 27, 2019
Prediction of drug response and adverse drug reactions: From twin studies to Next Generation SequencingVolker M Lauschke, Magnus Ingelman-Sundberg
Trends in Pharmacological Sciences|June 24, 2020
Can CYP Inhibition Overcome Chemotherapy Resistance?Magnus Ingelman-Sundberg, Volker M Lauschke
Clinical Pharmacology and Therapeutics|January 10, 2018
How to Consider Rare Genetic Variants in Personalized Drug TherapyVolker M Lauschke, Magnus Ingelman-Sundberg
Human Genomics|June 1, 2010
The Human Cytochrome P450 (CYP) Allele Nomenclature website: a peer-reviewed database of CYP variants and their associated effectsSarah C Sim, Magnus Ingelman-Sundberg
Pageof 29

Showing results (21-30 of 284) with videos related to

Sort By:
Pageof 29
Cellular Signalling|September 29, 2004
Regulation of aryl hydrocarbon receptor signal transduction by protein tyrosine kinasesMaria Backlund, Magnus Ingelman-Sundberg
Drug News & Perspectives|January 31, 2009
Current research in drug metabolism, drug transport and drug developmentInger Johansson, Magnus Ingelman-Sundberg
Expert Review of Clinical Pharmacology|January 16, 2014
Pharmacoepigenetic aspects of gene polymorphism on drug therapies: effects of DNA methylation on drug responseAlvin Gomez, Magnus Ingelman-Sundberg
Methods in Molecular Biology (Clifton, N.J.)|March 12, 2013
Update on allele nomenclature for human cytochromes P450 and the Human Cytochrome P450 Allele (CYP-allele) Nomenclature DatabaseSarah C Sim, Magnus Ingelman-Sundberg
NPJ Genomic Medicine|March 21, 2020
Emerging strategies to bridge the gap between pharmacogenomic research and its clinical implementationVolker M Lauschke, Magnus Ingelman-Sundberg
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 1, 2018
Current Statistical Metrics Are Pragmatic Measures to Compare the Predictive Quality of Preclinical AssaysMagnus Ingelman-Sundberg, Volker M Lauschke
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 27, 2019
Prediction of drug response and adverse drug reactions: From twin studies to Next Generation SequencingVolker M Lauschke, Magnus Ingelman-Sundberg
Trends in Pharmacological Sciences|June 24, 2020
Can CYP Inhibition Overcome Chemotherapy Resistance?Magnus Ingelman-Sundberg, Volker M Lauschke
Clinical Pharmacology and Therapeutics|January 10, 2018
How to Consider Rare Genetic Variants in Personalized Drug TherapyVolker M Lauschke, Magnus Ingelman-Sundberg
Human Genomics|June 1, 2010
The Human Cytochrome P450 (CYP) Allele Nomenclature website: a peer-reviewed database of CYP variants and their associated effectsSarah C Sim, Magnus Ingelman-Sundberg
Pageof 29